Metabolically favorable remodeling of human adipose tissue by human adenovirus type 36

Diabetes

Volumn 57, Issue 9, 2008, Pages 2321-2331

  Rogers, Pamela M ^a   Mashtalir, Nazar ^a   Rathod, Miloni A ^b   Dubuisson, Olga ^a   Wang, Zhong ^a   Dasuri, Kumar ^a   Babin, Scott ^a   Gupta, Alok ^a   Markward, Nathan ^a   Cefalu, William T ^a   Dhurandhar, Nikhil V ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; FATTY ACID SYNTHASE; INSULIN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; RAS PROTEIN; VIRUS ANTIBODY; GLUCOSE;

ADENOVIRUS INFECTION; ADIPOSE TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLYCEMIC CONTROL; HUMAN; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS 2; HUMAN ADENOVIRUS 36; HUMAN CELL; HUMAN TISSUE; INSULIN RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION; ADENOVIRUS; ADULT; BLOOD; CYTOLOGY; GENE THERAPY; GENETICS; IMMUNOLOGY; IN VITRO STUDY; LIPECTOMY; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY; TISSUE CULTURE TECHNIQUE; VIROLOGY; VIRUS INFECTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOVIRIDAE; ADENOVIRUS INFECTIONS, HUMAN; ADIPOSE TISSUE; ADULT; ANTIBODIES, VIRAL; DIABETES MELLITUS, TYPE 2; FEMALE; GENE THERAPY; GLUCOSE; HUMANS; LIPECTOMY; MIDDLE AGED; RAS PROTEINS; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; TISSUE CULTURE TECHNIQUES;

EID: 52749091092     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-1311     Document Type: Article

References (71)

1. Oh DK, Ciaraldi T, Henry RR: Adiponectin in health and disease. Diabetes Obes Metab 9:282-289, 2007
2. Bastard JP, Lagathu C, Maachi M, et al.: [Adipose tissue cytokines and insulin resistance]. J Annu Diabetol Hotel Dieu 29-37, 2004 [Article in French]
3. Capeau J, Magre J, Lascols O, et al.: Diseases of adipose tissue: genetic and acquired lipodystrophies. Biochem Soc Trans 33:1073-1077, 2005
4. Ranganathan G, Unal R, Pokrovskaya I, et al.: The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment. J Lipid Res 47:2444-2450, 2006
5. de Souza CJ, Eckhardt M, Gagen K, et al.: Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. Diabetes 50:1863-1871, 2001
6. Tarcin O, Bajaj M, Akalin S: Insulin resistance, adipocyte biology and thiazolidinediones: a review. Metab Syndr Relat Disord 5:103-115, 2007
7. Standaert ML, Kanoh Y, Sajan MP, et al.: Cbl, IRS-1, and IRS-2 mediate effects of rosiglitazone on PI3K, PKC-lambda, and glucose transport in 3T3/L1 adipocytes. Endocrinology 143:1705-1716, 2002
8. Todd MK, Watt MJ, Le J, et al.: Thiazolidinediones enhance skeletal muscle triacylglycerol synthesis while protecting against fatty acid-induced inflammation and insulin resistance. Am, J Physiol Endocrinol Metab 292:E485-E493, 2007
9. van Doorn M, Kemme M, Ouwens M, et al.: Evaluation of proinflammatory cytokines and inflammation markers as biomarkers for the action of thiazolidinediones in type 2 diabetes mellitus patients and healthy volunteers. Br J Clin Pharmacol 62:391-402, 2006
10. Yu JG, Javorschi S, Hevener AL, et al.: The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 51:2968-2974, 2002
11. Hu X, Feng Y, Liu X, et al.: Effect of a novel non-thiazolidinedione peroxisome proliferator-activated receptor alpha/gamma agonist on glucose uptake. Diabetologia 50:1048-1057, 2007
12. Smith SR, Xie H, Baghian S, et al.: Pioglitazone changes the distribution of adipocyte size in type 2 diabetes. Adipocytes 2:11-22, 2006
13. Medina-Gomez G, Gray SL, Yetukuri L, et al.: PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet 3:e64, 2007
14. Kim JY, van de Wall E, Laplante M, et al.: Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117:2621-2637, 2007
15. Dhurandhar NV, Israel BA, Kolesar JM, et al.: Transmissibility of adenovirus-induced adiposity in a chicken model. Int J Obes Relat Metab Disord 25:990-996, 2001
16. Dhurandhar NV, Israel BA, Kolesar JM, et al.: Increased adiposity in animals due to a human virus. Int J Obes Relat Metab Disord 24:989 -996, 2000
17. Dhurandhar NV, Whigham LD, Abbott DH, et al.: Human adenovirus Ad-36 promotes weight gain in male rhesus and marmoset monkeys. J Nutr 132:3155-3160, 2002
18. Pasarica M, Shin AC, Yu M, et al.: Human adenovirus 36 induces adiposity, increases insulin sensitivity, and alters hypothalamic monoamines in rats. Obesity (Silver Spring) 14:1905-1913, 2006
19. Vangipuram SD, Sheele J, Atkinson RL, et al.: A human adenovirus enhances preadipocyte differentiation. Obes Res 12:770-777, 2004
20. Rathod M, Vangipuram SD, Krishnan B, et al.: Viral mRNA expression but not DNA replication is required for lipogenic effect of human adenovirus Ad-36 in preadipocytes. Int J Obes (Lond) 31:78-86, 2007
21. Rathod MA, Rogers PM, Dhurandhar NV: Human adenovirus Ad-36 infection induces differentiation and replication of preadipocytes. Obes Rev 7:138, 2006
22. Vangipuram SD, Yu M, Tian J, et al.: Adipogenic human adenovirus-36 reduces leptin expression and secretion and increases glucose uptake by fat cells. Int J Obes (Lond) 31:87-96, 2007
23. Rogers PM, Fusinski K, Rathod MA, et al.: Human adenovirus Ad-36 induces adipogenesis via its E4 orf-1 gene. Int J Obes 32:397-406, 2007
24. Hanlon GW: Bacteriophages: an appraisal of their role in the treatment of bacterial infections. Int J Antimicrob Agents 30:118-128, 2007
25. Bischoff JR, Kirn DH, Williams A, et al.: An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274:373-376, 1996
26. Crompton AM, Kirn DH: From ONYX-015 to armed vaccinia viruses: the education and evolution of oncolytic virus development. Curr Cancer Drug Targets 7:133-139, 2007
27. Pan Q, Liu B, Liu J, et al.: Synergistic induction of tumor cell death by combining cisplatin with an oncolytic adenovirus carrying TRAIL. Mol Cell Biochem 304:315-323, 2007
28. Libertini S, Iacuzzo I, Ferraro A, et al.: Lovastatin enhances the replication of the oncolytic adenovirus dl1520 and its antineoplastic activity against anaplastic thyroid carcinoma cells. Endocrinology 148:5186-5194, 2007
29. Gesta S, Lolmede K, Daviaud D, et al.: Culture of human adipose tissue explants leads to profound alteration of adipocyte gene expression. Horm Metab Res 35:158-163, 2003
30. DeLany JP, Floyd ZE, Zvonic S, et al.: Proteomic analysis of primary cultures of human adipose-derived stem cells: modulation by adipogenesis. Mol Cell Proteomics 4:731-740, 2005
31. Stolic M, Russell A, Hutley L, et al.: Glucose uptake and insulin action in human adipose tissue: influence of BMI, anatomical depot and body fat distribution. Int J Obes Relat Metab Disord 26:17-23, 2002
32. R Development Core Team: R: A Language and Environment for Statistical Computing. Vienna, Austria, R Foundation for Statistical Computing, 2007
33. Whigham LD, Israel BA, Atkinson RL: Adipogenic potential of multiple human adenoviruses in vivo and in vitro in animals. Am J Physiol Regul Integr Comp Physiol 290:R190-R194, 2006
34. Enan E, Matsumura F: 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-induced changes in glucose transporting activity in guinea pigs, mice, and rats in vivo and in vitro. J Biochem Toxicol 9:97-106, 1994
35. Halleux CM, Servais I, Reul BA, et al.: Multihormonal control of ob gene expression and leptin secretion from cultured human visceral adipose tissue: increased responsiveness to glucocorticoids in obesity. J Clin Endocrinol Metab 83:902-910, 1998
36. Di Gregorio GB, Yao-Borengasser A, Rasouli N, et al.: Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes 54:2305-2313, 2005
37. Wang ZQ, Cefalu WT, Zhang XH, et al.: Human adenovirus type 36 enhances glucose uptake in diabetic and non-diabetic human skeletal muscle cells independent of insulin signaling. Diabetes, 57:1805-1813, 2008
38. Sakaue H, Ogawa W, Matsumoto M, et al.: Posttranscriptional control of adipocyte differentiation through activation of phosphoinositide 3-kinase. J Biol Chem 273:28945-28952, 1998
39. Tomiyama K, Nakata H, Sasa H, et al.: Wortmannin, a specific phosphatidylinositol 3-kinase inhibitor, inhibits adipocytic differentiation of 3T3-L1 cells. Biochem Biophys Res Commun 212:263-269, 1995
40. Cong L, Chen K, Li J, et al.: Regulation of adiponectin and leptin secretion and expression by insulin through a PI3K-PDE3B dependent mechanism in rat primary adipocytes. Biochem J 403:519-525, 2007
41. Zhang WJ, Wei H, Hagen T, et al.: Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway. Proc Natl Acad SciUSA 104:4077-4082, 2007
42. Bandyopadhyay G, Sajan MP, Kanoh Y, Standaert ML, Quon MJ, Lea-Currie R, Sen A, Farese RV: PKC-zeta mediates insulin effects on glucose transport in cultured preadipocyte-derived human adipocytes. J Clin Endocrinol Metab 87:716-723, 2002
43. Li E, Stupack D, Klemke R, et al.: Adenovirus endocytosis via alpha(v) integrins requires phosphoinositide-3-OH kinase. J Virol 72:2055-2061, 1998
44. Li E, Stupack DG, Brown SL, et al.: Association of p130CAS with phosphatidylinositol-3-OH kinase mediates adenovirus cell entry. J Biol Chem 275:14729-14735, 2000
45. Rajala MS, Rajala RV, Astley RA, et al.: Corneal cell survival in adenovirus type 19 infection requires phosphoinositide 3-kinase/Akt activation. JVirol 79:12332-12341, 2005
46. Frese KK, Lee SS, Thomas DL, et al.: Selective PDZ protein-dependent stimulation of phosphatidylinositol 3-kinase by the adenovirus E4-ORF1 oncoprotein. Oncogene 22:710-721, 2003
47. Frese KK, Latorre IJ, Chung SH, et al.: Oncogenic function for the Dlg1 mammalian homolog of the Drosophila discs-large tumor suppressor. EMBO J 25:1406-1417, 2006
48. Tan PH, Xue SA, Manunta M, et al.: Effect ofvectors on human endothelial cell signal transduction: implications for cardiovascular gene therapy. Arterioscler Thromb Vasc Biol 26:462-467, 2006
49. Esposito DL, Li Y, Cama A, et al.: Tyr(612) and Tyr(632) in human insulin receptor substrate-1 are important for full activation of insulin-stimulated phosphatidylinositol 3-kinase activity and translocation of GLUT4 in adipose cells. Endocrinology 142:2833-2840, 2001
50. Orme MH, Alrubaie S, Bradley GL, et al.: Input from Ras is required for maximal PI(3)K signalling in Drosophila. Nat Cell Biol 8:1298-1302, 2006
51. Suire S, Condliffe AM, Ferguson GJ, et al.: Gbetagammas and the Ras binding domain of p110gamma are both important regulators of PI(3)Kgamma signalling in neutrophils. Nat Cell Biol 8:1303-1309, 2006
52. Houseknecht KL, Zhu AX, Gnudi L, et al.: Overexpression of Ha-ras selectively in adipose tissue of transgenic mice: evidence for enhanced sensitivity to insulin. J Biol Chem 271:11347-11355, 1996
53. Tanti JF, Gremeaux T, Van Obberghen E, et al.: Insulin receptor substrate 1 is phosphorylated by the serine kinase activity of phosphatidylinositol 3-kinase. Biochem J 304:17-21, 1994
54. Ye J: Role of insulin in the pathogenesis of free fatty acid-induced insulin resistance in skeletal muscle. Endocr Metab Immune Disord Drug Targets 7:65-74, 2007
55. Sakaue M, Bowtell D, Kasuga M: A dominant-negative mutant of mSOS1 inhibits insulin-induced Ras activation and reveals Ras-dependent and -independent insulin signaling pathways. Mol Cell Biol 15:379-388, 1995
56. Mannova P, Beretta L: Activation of the N-Ras-PI3K-Akt-mTOR pathway by hepatitis C virus: control of cell survival and viral replication. J Virol 79:8742-8749, 2005
57. Ehrhardt C, Wolff T, Pleschka S, et al.: Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J Virol 81:3058-3067, 2007
58. Ahmed A, Thompson J, Emiliusen L, et al.: A conditionally replicating adenovirus targeted to tumor cells through activated RAS/P-MAPK-selective mRNA stabilization. Nat Biotechnol 21:771-777, 2003
59. Velcich A, Ziff E: Adenovirus E1a ras cooperation activity is separate from its positive and negative transcription regulatory functions. Mol Cell Biol 8:2177-2183, 1988
60. Bardell D: Glucose uptake and lactic acid production of adenovirus type 5-infected HEp-2 cells cultured under exponential growth and stationary phase conditions. Microbios 20:139-144, 1977
61. Atkinson R, Whigham L, Kim Y, et al.: Evaluation of human adenoviruses as an etiology of obesity in chickens. Am J Clin Nutr 75:380S, 2002
62. Xiao J, Chodosh J: JNK regulates MCP-1 expression in adenovirus type 19-infected human corneal fibroblasts. Invest Ophthalmol Vis Sci 46:3777-3782, 2005
63. Alcorn MJ, Booth JL, Coggeshall KM, et al.: Adenovirus type 7 induces interleukin-8 production via activation of extracellular regulated kinase 1/2. J Virol 75:6450-6459, 2001
64. Iacobelli-Martinez M, Nepomuceno RR, Connolly J, et al.: CD46-utilizing adenoviruses inhibit C/EBPbeta-dependent expression of proinflammatory cytokines. J Virol 79:11259-11268, 2005
65. Vilarrasa N, Vendrell J, Sanchez-Santos R, et al.: Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients. Clin Endocrinol (Oxf) 67:679-686, 2007
66. Engl J, Bobbert T, Ciardi C, et al.: Effects of pronounced weight loss on adiponectin oligomer composition and metabolic parameters. Obesity (Silver Spring) 15:1172-1178, 2007
67. Lin E, Phillips LS, Ziegler TR, et al.: Increases in adiponectin predict improved liver, but not peripheral, insulin sensitivity in severely obese women during weight loss. Diabetes 56:735-742, 2007
68. Jung SH, Park HS, Kim KS, Choi WH, Ahn CW, Kim BT, Kim SM, Lee SY, Ahn SM, Kim YK, Kim HJ, et al.: Effect of weight loss on some serum cytokines in human obesity: increase in IL-10 after weight loss. J Nutr Biochem 19:371-375, 2007
69. Bougoulia M, Triantos A, Koliakos G: Effect of weight loss with or without orlistat treatment on adipocytokines, inflammation, and oxidative markers in obese women. Hormones (Athens) 5:259 -269, 2006
70. Atkinson RL, Dhurandhar NV, Allison DB, et al.: Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int J Obes (Lond) 29:281-286, 2005
71. Pasarica M, Mashtalir N, McAllister EJ, et al.: Adipogenic human adenovirus Ad-36 induces commitment, differentiation and lipid accumulation in human adipose-derived stem cells. Stem Cells 26:969 -978, 2008